Find a Provider

• Advanced Malignancies
• Antiphospholipid
• Breast
• Cancer Prevention
• Cancers of the Digestive Tract
• Chronic Myelogenous Leukemia
• Colorectal (colon, rectum and anus)
• Esophageal Cancer
• Gastric Cancer
• Gastrointestinal Malignancies
• General Gynecology
• General Hematology
• General Oncology
• Genitourinary
• Geriatric Breast Cancer
• Geriatric Lung Cancer
• Gynecologic Oncology
• Head and Neck Cancers
• Hepatobiliary Cancers
• Laryngeal Cancer
• Liver Cancer
• Lung
• Lung Cancer
• Lung Cancer & Chest Malignancies
• Lymphoma
• Melanoma
• Multiple Myeloma
• Ovarian Cancer
• Pancreas
• Pancreatic Cancer
• Prostate Cancer
• Renal Cancer
• Sickle Cell Anemia
• Testicular Cancer
• Thoracic Cancer
• Unknown Primary
• Waldenstrom's Disease

• Breast Cancer
• Treating side effects of cancer therapy

1. Evaluation of an NP-based model of palliative care delivery within an oncology clinic. Sarah F. DAmbruoso, Neil Wenger, Anne Coscarelli, Sara A. Hurvitz, Christopher Pietras, Meghan Nechrebecki, Jennie Kung, Rena Desai Callahan, Jonathan Wade Goldman, Parvin F. Peddi, Drakaki Alexandra, Samuel A. Skootsky, and Anne Margaret Walling Journal of Clinical Oncology20173531_suppl163-163
2. R J Hartmaier, S E Trabucco, N Priedigkeit, J H Chung, C A Parachoniak, P Vanden Borre, S Morley, M Rosenzweig, L M Gay, M E Goldberg, J Suh, S M Ali, J Ross, B Leyland-Jones, B Young, C Williams, B Park, M Tsai, B Haley, J Peguero, R D Callahan, I Sachelarie, J Cho, J M Atkinson, A Bahreini, A M Nagle, S L Puhalla, R J Watters, Z Erdogan-Yildirim, L Cao, S Oesterreich, A Mathew, P C Lucas, N E Davidson, A M Brufsky, G M Frampton, P J Stephens, J Chmielecki, A V Lee; Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer, Annals of Oncology, Volume 29, Issue 4, 1 April 2018, Pages 872–880, https://doi.org/10.1093/annonc/mdy025
3. Jennifer S. Woo, Neda A. Moatamed, Peggy S. Sullivan, David Y. Lu, Rena Callahan et al. (2015) Comparison of Phosphohistone H3 Immunohistochemical Staining, Ki-67, and H&E Mitotic Count in Invasive Breast Carcinoma. Journal Of Breast Cancer Survival - 1(1):1-11.
4. Ponec, R., Peddi, P., Callahan, R. "Parp inhibitors in Breast Cancer: Latest Evidence." Current Breast Cancer Reports. Vol 9, 2017.
5. Rena Callahan. Ado-Trastuzumab Emtansine in Metastatic HER2-Positive Breast Cancer. J Adv Pract Oncol. 2014 Mar-Apr; 5(2): 134–139.
6. Rena D. Callahan, Patricia A. Ganz. “Side Effects of Systemic Therapy: Neurocognitive, Cardiac, and Secondary Malignancies.” Diseases of the Breast, 5th edition, Ed. Jay R. Harris, MD, Marc E. Lippman, MD, Monica Morrow, MD, and C. Kent Osborne, MD. Lippincott Williams and Wilkins, May 2014, 1224. ISBN: 978-1-4511-8627-7.
7. RD Callahan, SA Hurvitz. HER2-Positive Breast Cancer: Current Management of Early, Advanced, and Recurrent Disease. Current Opinions in Obstetrics and Gynecology, 2011 Feb. 23 (1):37-43.
8. R.Callahan, R. Patel, D.Chan, M.Allison, B. Dicarlo, L. Bosserman, A. Kennedy, L.M. Zehngebot, J. Miller, A.E. Giuliano, B. Spivack, L.S. Lin, D.J. Slamon, S.A. Hurvitz. Phase II Trial of Presurgical Treatment with Trastuzumab (H) or Lapatinib (Ty) or the Combination of Trastuzumab and Lapatinib (H+Ty), Followed by Six Cycles of Docetaxel (T) and Carboplatin (C) with Trastuzumab (TCH) or Lapatinib (TCTy) or the combination of Trastuzumab and Lapatinib (TCHTy) in Patients with HER2+ Breast Cancer. 2010 San Antonio Breast Cancer Symposium, December 2010.
9. Richard P. Tonino, Pierre J. Meunier, Ronald Emkey, Jose A. Rodriguez-Portales, Charles-Joel Menkes, Richard D. Wasnich, Henry G. Bone, Arthur C. Santora, Mei Wu, Rena Desai, and Philip D. Ross. “Skeletal benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women.” J. Clin. Endocrinol. Metab. 2000. 85: 3109-3115.
10. Rena Desai Callahan, K. Rajender Reddy. “Liver Disease in Pregnancy.” The Clinician’s Guide to Liver Disease. Ed. Reddy KR and Faust T. Philadelphia: Slack, 2006: 211-230.
11. Richard P. Tonino, Pierre J. Meunier, Ronald Emkey, Jose A. Rodriguez-Portales, Charles-Joel Menkes, Richard D. Wasnich, Henry G. Bone, Arthur C. Santora, Mei Wu, Rena Desai, and Philip D. Ross. “Efficacy and Tolerability of Alendronate (7 years), and Effect of Discontinuation.” The 8th Annual Congress on Women’s Health and Gender Based Medicine, Hilton Head, SC, June 2000.
12. Rena Desai, Kirti Shetty, Kim M. Olthoff, Abraham Shaked, Colleen M. Brensinger, K. Rajender Reddy. The Tokyo Score in the Prognosis of Hepatocellular Carcinoma. Young Investigator’s Forum, Controversies in Transplantation. March 2004.
13. Christopher Gasink, Stephen Rulyak, Stephen Rubesin, Rena Desai, James Lewis, Bernard Birnbaum, Jill E. Jacobs, Matthew Gardiner, Gary R. Lichtenstein. Ileal Thickening: Radiographic Features Predictive of Crohn's Disease on Abdominal CT Scan. Digestive Disease Week, May 2004.
14. Rena Callahan, Ashkan Lashkari, Baldeep Singh. Myositis Ossificans. Society for General Internal Medicine Annual Meeting, March 2006.

Winter 2016 Ask the Expert: Neoadjuvant Therapy - (lbbc.org)
The science of why human breasts are so big - (businessinsider.com)

Note: News links may expire without notice.

• Commendation for Excellence in Medical Student Teaching, UCLA, 2007
• Commendation for Excellence in Medical Student Teaching, UCLA, 2006
• Commendation for Excellence in Medical Student Teaching, UCLA, 2005
• Russell J. Stumacher Memorial Award, for academic and artistic excellence, University of Pennsylvania School of Medicine, 2004
• Glasgow Rubin Award, for academic excellence, University of Pennsylvania School of Medicine, 2004
• Alpha Omega Alpha medical honor society, inducted 2003 
• Yale Class of 1956, Summer Fellowship for Study Abroad, 1996

Medical Education